ahc 52 has been researched along with etoposide in 1 studies
| Studies (ahc 52) | Trials (ahc 52) | Recent Studies (post-2010) (ahc 52) | Studies (etoposide) | Trials (etoposide) | Recent Studies (post-2010) (etoposide) |
|---|---|---|---|---|---|
| 7 | 0 | 0 | 18,306 | 3,693 | 4,900 |
| Protein | Taxonomy | ahc 52 (IC50) | etoposide (IC50) |
|---|---|---|---|
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | Homo sapiens (human) | 1.153 | |
| nuclear receptor coactivator 3 isoform a | Homo sapiens (human) | 1.4284 | |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | Oryctolagus cuniculus (rabbit) | 3.187 | |
| Caspase-3 | Homo sapiens (human) | 1 | |
| DNA topoisomerase 2-beta | Homo sapiens (human) | 0.4299 | |
| Solute carrier organic anion transporter family member 1B3 | Homo sapiens (human) | 4.18 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ebisu, H; Inaba, M; Mitsuhashi, J; Shinoda, H; Tsuruo, T | 1 |
1 other study(ies) available for ahc 52 and etoposide
| Article | Year |
|---|---|
Therapeutic efficacy of combination of antitumor agent with AHC-52 against multidrug-resistant cells in the intravenously inoculated P388 leukemia model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Dihydropyridines; Doxorubicin; Drug Resistance; Drug Synergism; Etoposide; Female; Leukemia P388; Mice; Mice, Inbred BALB C; Mice, Inbred DBA; Pyrazoles; Vincristine | 1992 |